ResOs

National network specialized in pathology and care of bone sarcomas

SarcomaBCB

L’ANSM suspend les essais masitinib promus par AB Science. Le GSF-GETO recommande imatinib ou sunitinib en remplacement.

About ResOS
National network specialized in pathology and care of bone sarcomas
Scientific contact
Scientific team
Technical contact
Support team